Hyalinising clear cell carcinoma of salivary gland: a case report
DOI:
https://doi.org/10.15584/ejcem.2020.2.8Keywords:
cancer, hyalinising clear cell carcinoma, salivary glandAbstract
Introduction. Clear cell carcinoma, not otherwise specified/hyalinising clear cell carcinoma of the salivary gland (HCCC) is a malignancy that arises in minor salivary glands. It rarely leads to distant metastases or cancer-related death but has the potential for recurrence and focal metastases.
Aim. A case is reported.
Description of the case. A 72 years old female patient has reported to the Clinic of Otolaryngology with a tongue lesion. The patient had no history of malignancy. The lymph node has been surgically removed for further examination. Cords and nests of clear cells and cells with eosinophilic cytoplasm in a hyalinized stroma were identified within the lymph node. After the diagnosis the patient has been transferred to another Oncology Hospital for further treatment.
Conclusion. The diagnosis of clear cell carcinoma may be challenging because many of it‘s features frequently overlap with other salivary gland lesions.
Downloads
References
Baghirath PV, Kumar JV, Vinay BH. Hyalinizing clear cell carcinoma: A rare entity. J Oral Maxillofac Pathol. 2011;15(3):335-339.
Antonescu CR, Katabi N, Zhang L. EWSR1-ATF1 fusion is a novel and consistent finding in hyalinizing clear-cell carcinoma of salivary gland. Gen Chrom Cancer. 2011;50:559-570.
Milchgrub S, Gnepp DR, Vuitch F, Delgado R, Albores-Saavedra J. Hyalinizing clear cell carcinoma of salivary gland. Am J Surg Pathol. 1994;18:74-82.
O’Sullivan-Mejia ED, Massey HD, Faquin WC, Powers CN. Hyalinizing clear cell carcinoma: report of eight cases and review of literature. Head Neck Pathol. 2009;3:179-185.
Weinreb I. Hyalinizing clear cell carcinoma of salivary gland: a review and update. Head Neck Pathol. 2013;7 Suppl 1:S20-29.
Curti BD. Renal cell carcinoma. J Amer Med Assoc. 2004; 292(1):97-100.
Powles T, Albiges L, Staehler M, et al. Updated European Association of Urology Guidelines recommendations for the treatment of first-line metastatic clear cell renal cancer. Eur Urol. 2018;73(3):311-315.
Cohen HT, McGovern FJ. Renal-cell carcinoma. N Engl J Med. 2005;353(23):2477-2490.
Lieder A, Guenzel T, Lebentrau S, Schneider C, Franzen A. Diagnostic relevance of metastatic renal cell carcinoma in the head and neck: An evaluation of 22 cases in 671 patients. Int Braz J Urol. 2017;43(2):202-208.
Wang C, Takeda K, Shiba M, Takayama H, Munakata S. Metastasis to the Tongue from Renal Cell Carcinoma 10 Years after Nephrectomy: A Case Report. Hinyokika Kiyo. 2016;62(8):407-410.
McHugh JB, Hoschar AP, Dvorakova M, Parwani AV, Barnes EL, Seethala RR. p63 immunohistochemistry differentiates salivary gland oncocytoma and oncocytic carcinoma from metastatic renal cell carcinoma. Head Neck Pathol. 2007;1(2):123-131.
Ng JH, Iyer NG, Tan M-H, Edgren G. Changing epidemiology of oral squamous cell carcinoma of the tongue: A global study. Head Neck. 2017;39(2):297-304.
Donohue-Cornejo A, Paes de Almeida O, Sánchez-Romero C, Espinosa-Cristóbal LF, Reyes-López SY, Cuevas-González JC. Hyalinizing clear cell carcinoma-a rare entity in the oral cavity: A case report. World J Clin Cases. 2020;8(1):133-139.
Hornick JL, Fletcher CD. Myoepithelial tumors of soft tissue: a clinicopathologic and immunohistochemical study of 101 cases with evaluation of prognostic parameters. Am J Surg Pathol. 2003;27:1183-1196.
Krishnamurthy A, Ramshankar V, Majhi U. Clear cell odontogenic carcinoma of the mandible and temporomandibuar joint with cervical lymph nodal metastasis. Natl J Maxillofac Surg. 2014;5(2):221-223.
Orning JL, Trembath DG, Zanation AM. Endoscopic endonasal approach for resection of infundibular granular cell tumor: Case Report and Literature Review. J Case Rep Med. 2013;2:235775.
Saleh KA, Nurishmah MI, Firouzeh GN, Goh BS. Primary clear cell carcinoma of minor salivary gland of the soft palate: a case report. Med J Malaysia. 2012;67(3):335-336.
Baghirath PV, Kumar JV, Vinay BH, Hyalinizing clear cell carcinoma: A rare entity. J Oral Maxillofac Pathol. 2011;15(3):335-339.
Masilamani S, Rao S, Chirakkal P, Kumar AR, Hyalinizing clear cell carcinoma of the base of tongue: a distinct and rare entity. Indian J Pathol Microbiol. 2011;54(1):167-169.
Jeffus SK, Gardner JM, Steliga MA, Shah AA, Stelow EB, Arnaoutakis K. Hyalinizing clear cell carcinoma of the lung: Case report and review of the literature. Am J Clin Pathol. 2017;148(1):73-80.
Salgia NJ, Dara Y, Bergerot P, Salgia M, Pal SK. The changing landscape of management of metastatic renal cell carcinoma: current treatment options and future directions. Curr Treat Options Oncol. 2019;20(5):41-45.
Reinhorn D, Sarfaty M, Leshno M, et al. A Cost-Effectiveness analysis of nivolumab and ipilimumab versus sunitinib in first-line intermediate- to poor-risk advanced renal cell carcinoma. Oncologist. 2019;24(3):366-371.
Oliver J, Wu P, Chang C, Roden D, Wang B, Liu C, Hu K, Schreiber D, Givi B. Patterns of care and outcome of clear cell carcinoma of the head and neck. Otolaryngol Head Neck Surg. 2019;161(1):98-104.
Icard B, Grider DJ, Aziz S, Rubio E. Primary tracheal hyalinizing clear cell carcinoma. Lung Cancer. 2018;125:100-102.
Takamatsu M, Sato Y, Muto M, et al. Hyalinizing clear cell carcinoma of the bronchial glands: presentation of three cases and pathological comparisons with salivary gland counterparts and bronchial mucoepidermoid carcinomas. Mod Pathol. 2018;31(6):923-933.
Skálová A, Stenman G, Simpson RHW, et al. The Role of Molecular Testing in the Differential Diagnosis of Salivary Gland Carcinomas. Am J Surg Pathol. 2018 ;42(2):e11-e27.
Jeffus SK, Gardner JM, Steliga MA, Shah AA, Stelow EB, Arnaoutakis K. Hyalinizing clear cell carcinoma of the lung: Case report and review of the literature. Am J Clin Pathol. 2017;148(1):73-80.
Burgess B, Ananthanarayanan V, Charous S. Hyalinizing Clear Cell Carcinoma of the Tonsil: A Case Report. Head Neck Pathol. 2017;11(4):580-583.
Lan J, Huang SC, Chen YH, Chen WC, Jin YT, Lu YC, Chien CY, Huang HY. Primary paranasal sinus clear cell carcinoma with EWSR1-ATF1 fusion: report of 2 molecularly confirmed cases exhibiting unique histopathology. Hum Pathol. 2017;63:139-143.
Skálová A, Šteiner P, Vaneček T. New developments in molecular diagnostics of carcinomas of the salivary glands: "translocation carcinomas". Cesk Pathol. 2016;52(3):139-145.
Ni H, Wang XT, Xia QY, Wang X, Li R, Yang WR, Wei X, Gong X, Zhou XJ, Rao Q. Zhonghua Bing Li Xue Za Zhi. Hyalinizing clear cell carcinoma of salivary gland: a clinicopathologic study. Head Neck Pathol. 2016;45(8):577-578.
Falk N, Weissferdt A, Kalhor N, Moran CA. Primary Pulmonary Salivary Gland-type Tumors: A Review and Update. Adv Anat Pathol. 2016;23(1):13-23.
Lin JC, Liao JB, Fu HT, Chang TS, Wang JS. Salivary gland hyalinizing clear cell carcinoma. J Pathol Transl Med. 2015;49(4):351-353.
Fukuda A, Tagami Y, Takasawa A, et al. Nasopharyngeal hyalinizing clear cell carcinoma with EWSR1 rearrangements diagnosed by fluorescence in situ hybridization. Auris Nasus Larynx. 2015;42(5):412-415.
Skálová A, Weinreb I, Hyrcza M, et al. Clear cell myoepithelial carcinoma of salivary glands showing EWSR1 rearrangement: molecular analysis of 94 salivary gland carcinomas with prominent clear cell component. Am J Surg Pathol. 2015;39(3):338-348.
García JJ, Jin L, Jackson SB, Larsen BT, Lewis JE, Sukov WR, Roden AC. Primary pulmonary hyalinizing clear cell carcinoma of bronchial submucosal gland origin. Hum Pathol. 2015;46(3):471-475.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 European Journal of Clinical and Experimental Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
